Urinary Stress Incontinence
Conditions
Keywords
Urinary Stress Incontinence, Radiofrequency, Women
Brief summary
Urinary stress incontinence ( SUI ) is defined as an involuntary loss of urinary Complaint no effort According to the Consensus of the International Continence Society (Society Continence International - ICS) . SUI Prevalence of adult female Population and 25 % to 30 %.However, despite the high prevalence, many women who have symptoms of SUI or not seek treatment remain without resolution of symptoms.Then there is the possibility of using non-invasive radiofrequency and non-ablation in external urethral meatus in order to stimulate collagen production, as one of the pathophysiological mechanisms of stress urinary incontinence is the collagen deficit in the urethral wall. It is a randomized clinical trial and the group experimental will utilize radiofrequency and kinesiotheraphy ( clinical and in home) and the group control utilize turn off- radiofrequency and kinesiotherapy (clinical and in home). The protocol f the kinesiotherapy is the same both the group, and the protocol radiofrequency the group experimental will 5 sessions (one per week) with temperature 38ºC during 2 minutes. The group control will 5 sessions (one per week) but the radiofrequency will off but glycerin is heated, for masking for the patient, during 2 min. The result of the treatment is assessed by pad test 1 hour and have others outcomes ( quality of life- Sf-26 ans King Health- and sexual function- FSFI questionaire)
Interventions
DEVICERadiofrequency
The radiofrequency is a noninvasive technique that will be applied to the external urethral meatus region.It will use a digital thermometer with infrared to mention the temperature should reach 39 ° C and maintain this temperature for 2 minutes.It will use a digital thermometer with infrared to mention the temperature should reach 39 ° C and maintain this temperature for 2 minutes
DEVICERadiofrequency OFF
Will be used to put off radio frequency will be heated glycerin to occur masking for the patient.
Sponsors
Centro de Atenção ao Assoalho Pélvico
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 59 Years
Healthy volunteers
Yes
Inclusion criteria
* 21 Women with age between 18-59 years old, * women with diagnosis of urinary incontinence and have a Pelvic floor muscle contractility was assessed by digital palpation using the validated Modified Oxford Scale (MOS) greater than or equal to three
Exclusion criteria
* Patients with cognitive deficits or psychiatric illness; * suffering from chronic degenerative neurological diseases; which have greater than 50 ml post-voiding residue ; * sensory deficit in the genital region; * people with pacemakers and implantable cardioverter-defibrillator and pregnant women will be excluded from the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Urinary loss modification | one week, one month, two month , three month and six month | The pad test will be held at the beginning of treatment and one week, one month, two month, three month and six month after the last session of radio frequency. The pad test it quantifies in grams urinary loss through the absorbent weighing. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| specific Quality of life | one week | The quality of life will be assessed by one for specific urinary symptoms - Health King , measure with unit of the scale |
| Sexual Function | one week | Will be evaluated before and after radio frequency sexual function of women, through questionary FSFI in which there is a switching station which evaluates the presence of sexual dysfunction, and there is specific scores for the domains of pain, desire, lubrication, arousal, orgasm, and satisfaction. |
| overall quality of life | one week | Will be evaluated before and after radio frequency the overall quality of life - SF-36 - questionaire. |
Countries
Brazil
Contacts
Primary ContactPatricia V Lordelo, Phd
Outcome results
None listed